These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26707036)

  • 1. Periodontitis and osteoporosis.
    Straka M; Straka-Trapezanlidis M; Deglovic J; Varga I
    Neuro Endocrinol Lett; 2015; 36(5):401-6. PubMed ID: 26707036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between osteoporosis treatment and severe periodontitis in postmenopausal women.
    Passos-Soares JS; Vianna MIP; Gomes-Filho IS; Cruz SS; Barreto ML; Adan LF; Rösing CK; Trindade SC; Cerqueira EMM; Scannapieco FA
    Menopause; 2017 Jul; 24(7):789-795. PubMed ID: 28225430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis/osteopenia as an independent factor associated with periodontitis in postmenopausal women: a case-control study.
    Passos JS; Vianna MI; Gomes-Filho IS; Cruz SS; Barreto ML; Adan L; Rösing CK; Cerqueira EM; Trindade SC; Coelho JM
    Osteoporos Int; 2013 Apr; 24(4):1275-83. PubMed ID: 23001114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women.
    Reinhardt RA; Payne JB; Maze CA; Patil KD; Gallagher SJ; Mattson JS
    J Periodontol; 1999 Aug; 70(8):823-8. PubMed ID: 10476887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes to the periodontium in postmenopausal women].
    Kaźmierczak W; Fiegler P; Przybyłek K; Kamiński K; Fiegler-Mecik H; Wegrzyn P
    Ginekol Pol; 2005 Feb; 76(2):163-7. PubMed ID: 15847085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment?
    Laster AJ; Tanner SB
    Rheum Dis Clin North Am; 2011 Aug; 37(3):323-36, v. PubMed ID: 22023894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination anabolic and antiresorptive therapy for osteoporosis.
    Cusano NE; Bilezikian JP
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):643-54. PubMed ID: 22877434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal assessment of postmenopausal women receiving risedronate.
    Palomo L; Bissada NF; Liu J
    Menopause; 2005; 12(6):685-90. PubMed ID: 16278611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis, fragility fracture, and periodontal disease: a cross-sectional study in Spanish postmenopausal women.
    Martínez-Maestre MA; Machuca G; González-Cejudo C; Flores JR; Cardoso RT; Castelo-Branco C
    Menopause; 2013 Jan; 20(1):79-84. PubMed ID: 22914207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodontitis and stroke.
    Straka M; Trapezanlidis M
    Neuro Endocrinol Lett; 2013; 34(3):200-6. PubMed ID: 23685417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What to use to treat osteoporosis?].
    Välimäki MJ
    Duodecim; 2003; 119(24):2409-12. PubMed ID: 14870501
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis: a possible modifying factor in oral bone loss.
    Jeffcoat MK
    Ann Periodontol; 1998 Jul; 3(1):312-21. PubMed ID: 9722715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral implications of osteoporosis.
    Dervis E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Sep; 100(3):349-56. PubMed ID: 16122665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone turnover markers: a key tool for understanding osteoporosis.
    Eastell R; Ebeling PR
    Osteoporos Int; 2009 May; 20 Suppl 3():S237-8. PubMed ID: 19430871
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.